Neuropeptide Y in the noradrenergic neurones induces obesity and inhibits sympathetic tone in mice

Acta Physiologica

Volumn 213, Issue 4, 2015, Pages 902-919

  Vahatalo L H ^a   Ruohonen, S T ^a   Makela S ^a   Kovalainen, M ^b,c   Huotari, A ^b,c   Makela K A ^c   Maatta J A ^a   Miinalainen, I ^c   Gilsbach, R ^d   Hein, L ^d   Ailanen, L ^a   Mattila, M ^a   Eerola, K ^a   Roytta M ^a   Ruohonen, S ^a,e   Herzig, K H ^c,f   Savontaus, E ^a,g  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d UNIVERSITY OF FREIBURG   (Germany)

^e UNIVERSITY OF TURKU   (Finland)

^f MEDICAL RESEARCH CENTER OULU   (Finland)

^g TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Adipose tissue; Glucose tolerance; Mice; Neuropeptide Y; Obesity; Sympathetic nervous system

Indexed keywords

ADRENALIN; BIOLOGICAL MARKER; CATECHOLAMINE; FATTY ACID; GHRELIN; GLUCOSE; INSULIN; LIPID; NEUROPEPTIDE Y; MESSENGER RNA;

ADIPOCYTE; ADIPOSE TISSUE; ADRENALIN URINE LEVEL; ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY FAT DISTRIBUTION; BODY TEMPERATURE; BROWN ADIPOCYTE; BROWN ADIPOSE TISSUE; CALORIC INTAKE; CATECHOLAMINE NERVE CELL; CATECHOLAMINE URINE LEVEL; COLD EXPOSURE; CONTROLLED STUDY; ENERGY EXPENDITURE; FEMALE; FOOD INTAKE; GENE OVEREXPRESSION; GENOTYPE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIPID ABSORPTION; LIPID BLOOD LEVEL; LIPID STORAGE; LIPID TRANSPORT; LIPOLYSIS; MALE; MOUSE; NONHUMAN; NORADRENERGIC NERVE CELL; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYMPATHETIC TONE; THERMOGENESIS; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; ADRENERGIC NERVE CELL; ADRENERGIC SYSTEM; ANIMAL; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENETICS; HYPOTHALAMUS; METABOLISM; PHYSIOLOGY;

ADIPOSE TISSUE, BROWN; ADRENERGIC NEURONS; ANIMALS; ENERGY METABOLISM; GENE EXPRESSION REGULATION; HYPOTHALAMUS; MICE; MICE, TRANSGENIC; NEUROPEPTIDE Y; OBESITY; RNA, MESSENGER; SYMPATHETIC NERVOUS SYSTEM;

EID: 84924678622     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12436     Document Type: Article

References (60)

1. Arbeeny, C.M., Meyers, D.S., Hillyer, D.E. & Bergquist, K.E. 1995. Metabolic alterations associated with the antidiabetic effect of beta 3-adrenergic receptor agonists in obese mice. Am J Physiol 268, E678-E684.
2. Baldock, P.A., Lee, N.J., Driessler, F., Lin, S., Allison, S., Stehrer, B., Lin, E.J., Zhang, L., Enriquez, R.F., Wong, I.P. et al. 2009. Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight. PLoS ONE 4, e8415.
3. Balhorn, R. 2007. The protamine family of sperm nuclear proteins. Genome Biol 8, 227.
4. Berger, J.J. & Barnard, R.J. 1999. Effect of diet on fat cell size and hormone-sensitive lipase activity. J Appl Physiol (1985), 87, 227-232.
5. Billington, C.J., Briggs, J.E., Grace, M. & Levine, A.S. 1991. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am J Physiol 260, R321-R327.
6. Bradley, R.L., Mansfield, J.P. & Maratos-Flier, E. 2005. Neuropeptides, including neuropeptide Y and melanocortins, mediate lipolysis in murine adipocytes. Obes Res 13, 653-661.
7. Callewaert, F., Venken, K., Kopchick, J.J., Torcasio, A., van Lenthe, G.H., Boonen, S. & Vanderschueren, D. 2010. Sexual dimorphism in cortical bone size and strength but not density is determined by independent and time-specific actions of sex steroids and IGF-1: evidence from pubertal mouse models. J Bone Miner Res 25, 617-626.
8. Cavadas, C., Cefai, D., Rosmaninho-Salgado, J., Vieira-Coelho, M.A., Moura, E., Busso, N., Pedrazzini, T., Grand, D., Rotman, S., Waeber, B., Aubert, J.F. & Grouzmann, E. 2006. Deletion of the neuropeptide Y (NPY) Y1 receptor gene reveals a regulatory role of NPY on catecholamine synthesis and secretion. Proc Natl Acad Sci USA 103, 10497-10502.
9. Chapados, N., Collin, P., Imbeault, P., Corriveau, P. & Lavoie, J.M. 2008. Exercise training decreases in vitro stimulated lipolysis in a visceral (mesenteric) but not in the retroperitoneal fat depot of high-fat-fed rats. Br J Nutr 100, 518-525.
10. Corp, E.S., Melville, L.D., Greenberg, D., Gibbs, J. & Smith, G.P. 1990. Effect of fourth ventricular neuropeptide Y and peptide YY on ingestive and other behaviors. Am J Physiol 259, R317-R323.
11. Cox, H.M. 2007. Neuropeptide Y receptors; antisecretory control of intestinal epithelial function. Auton Neurosci 133, 76-85.
12. Di Girolamo, M., Mendlinger, S. & Fertig, J.W. 1971. A simple method to determine fat cell size and number in four mammalian species. Am J Physiol 221, 850-858.
13. Ding, B., Kull, B., Liu, Z., Mottagui-Tabar, S., Thonberg, H., Gu, H.F., Brookes, A.J., Grundemar, L., Karlsson, C., Hamsten, A. et al. 2005. Human neuropeptide Y signal peptide gain-of-function polymorphism is associated with increased body mass index: possible mode of function. Regul Pept 127, 45-53.
14. Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A.F., Beil, F.T., Shen, J., Vinson, C., Rueger, J.M. & Karsenty, G. 2000. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100, 197-207.
15. Ekblad, E., Edvinsson, L., Wahlestedt, C., Uddman, R., Hakanson, R. & Sundler, F. 1984. Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul Pept 8, 225-235.
16. Erickson, J.C., Hollopeter, G. & Palmiter, R.D. 1996. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274, 1704-1707.
17. Everitt, B.J., Hokfelt, T., Terenius, L., Tatemoto, K., Mutt, V. & Goldstein, M. 1984. Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience 11, 443-462.
18. Folch, J., Lees, M. & Sloane Stanley, G.H. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497-509.
19. Fujimiya, M. & Inui, A. 2000. Peptidergic regulation of gastrointestinal motility in rodents. Peptides 21, 1565-1582.
20. Gilsbach, R., Brede, M., Beetz, N., Moura, E., Muthig, V., Gerstner, C., Barreto, F., Neubauer, S., Vieira-Coelho, M.A. & Hein, L. 2007. Heterozygous alpha 2C-adrenoceptor-deficient mice develop heart failure after transverse aortic constriction. Cardiovasc Res 75, 728-737.
21. Green, A., Carroll, R.M. & Dobias, S.B. 1996. Desensitization of beta-adrenergic receptors in adipocytes causes increased insulin sensitivity of glucose transport. Am J Physiol 271, E271-E276.
22. Gulbenkian, S., Wharton, J., Hacker, G.W., Varndell, I.M., Bloom, S.R. & Polak, J.M. 1985. Co-localization of neuropeptide tyrosine (NPY) and its C-terminal flanking peptide (C-PON). Peptides 6, 1237-1243.
23. Haukkala, J., Laitinen, I., Luoto, P., Iveson, P., Wilson, I., Karlsen, H., Cuthbertson, A., Laine, J., Leppänen, P., Ylä-Herttula, S., Knuuti, J. & Roivainen, A. 2009. 68 Ga-DOTA-RGD peptide: biodistribution and binding into atherosclerotic plaques in mice. Eur J Nucl Med Mol Imaging 36, 2058-2067.
24. Kallio, J., Pesonen, U., Kaipio, K., Karvonen, M.K., Jaakkola, U., Heinonen, O.J., Uusitupa, M.I. & Koulu, M. 2001. Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans. FASEB J 15, 1242-1244.
25. Kallio, J., Pesonen, U., Jaakkola, U., Karvonen, M.K., Helenius, H. & Koulu, M. 2003. Changes in diurnal sympathoadrenal balance and pituitary hormone secretion in subjects with Leu7Pro polymorphism in the prepro-neuropeptide Y. J Clin Endocrinol Metab 88, 3278-3283.
26. Karvonen, M.K., Koulu, M., Pesonen, U., Uusitupa, M.I., Tammi, A., Viikari, J., Simell, O. & Rönnemaa, T. 2000. Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with birth weight and serum triglyceride concentration in preschool aged children. J Clin Endocrinol Metab 85, 1455-1460.
27. Kuo, L.E., Kitlinska, J.B., Tilan, J.U., Li, L., Baker, S.B., Johnson, M.D., Lee, E.W., Burnett, M.S., Fricke, S.T., Kvetnansky, R., Herzog, H. & Zukowska, Z. 2007. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 13, 803-811.
28. Kuo, L.E., Czarnecka, M., Kitlinska, J.B., Tilan, J.U., Kvetnansky, R. & Zukowska, Z. 2008. Chronic stress, combined with a high-fat/high-sugar diet, shifts sympathetic signaling toward neuropeptide Y and leads to obesity and the metabolic syndrome. Ann N Y Acad Sci 1148, 232-237.
29. Lee, K., Haugen, H.S., Clegg, C.H. & Braun, R.E. 1995. Premature translation of protamine 1 mRNA causes precocious nuclear condensation and arrests spermatid differentiation in mice. Proc Natl Acad Sci USA 92, 12451-12455.
30. Li, A.J., Wang, Q., Dinh, T.T. & Ritter, S. 2009. Simultaneous silencing of Npy and Dbh expression in hindbrain A1/C1 catecholamine cells suppresses glucoprivic feeding. J Neurosci 29, 280-287.
31. Matic, I., Matthews, B.G., Kizivat, T., Igwe, J.C., Marijanovic, I., Ruohonen, S.T., Savontaus, E., Adams, D.J. & Kalajzic, I. 2012. Bone-specific overexpression of NPY modulates osteogenesis. J Musculoskelet Neuronal Interact 12, 209-218.
32. Michalkiewicz, M., Michalkiewicz, T., Kreulen, D.L. & McDougall, S.J. 2001. Increased blood pressure responses in neuropeptide Y transgenic rats. Am J Physiol Regul Integr Comp Physiol 281, R417-R426.
33. Miinalainen, I.J., Schmitz, W., Huotari, A., Autio, K.J., Soininen, R., Ver Loren van Themaat, E., Baes, M., Herzig, K.H., Conzelmann, E. & Hiltunen, J.K. 2009. Mitochondrial 2, 4-dienoyl-CoA reductase deficiency in mice results in severe hypoglycemia with stress intolerance and unimpaired ketogenesis. PLoS Genet 5, e1000543.
34. Mitchell, G.C., Wang, Q., Ramamoorthy, P. & Whim, M.D. 2008. A common single nucleotide polymorphism alters the synthesis and secretion of neuropeptide Y. J Neurosci 28, 14428-14434.
35. Mundinger, T.O., Cummings, D.E. & Taborsky, G.J. Jr 2006. Direct stimulation of ghrelin secretion by sympathetic nerves. Endocrinology 147, 2893-2901.
36. Pesonen, U. 2008. NPY L7P polymorphism and metabolic diseases. Regul Pept 149, 51-55.
37. Pilvi, T.K., Seppänen-Laakso, T., Simolin, H., Finckenberg, P., Huotari, A., Herzig, K.H., Korpela, R., Oresic, M. & Mervaala, E.M. 2008. Metabolomic changes in fatty liver can be modified by dietary protein and calcium during energy restriction. World J Gastroenterol 14, 4462-4472.
38. Renshaw, D., Thomson, L.M., Carroll, M., Kapas, S. & Hinson, J.P. 2000. Actions of neuropeptide Y on the rat adrenal cortex. Endocrinology 141, 169-173.
39. Ruohonen, S.T., Pesonen, U., Moritz, N., Kaipio, K., Röyttä, M., Koulu, M. & Savontaus, E. 2008. Transgenic mice overexpressing neuropeptide Y in noradrenergic neurons: a novel model of increased adiposity and impaired glucose tolerance. Diabetes 57, 1517-1525.
40. Ruohonen, S.T., Savontaus, E., Rinne, P., Rosmaninho-Salgado, J., Cavadas, C., Ruskoaho, H., Koulu, M. & Pesonen, U. 2009. Stress-induced hypertension and increased sympathetic activity in mice overexpressing neuropeptide Y in noradrenergic neurons. Neuroendocrinology 89, 351-360.
41. Ruohonen, S.T., Vähätalo, L.H. & Savontaus, E. 2012. Diet-induced obesity in mice overexpressing neuropeptide y in noradrenergic neurons. Int J Pept 2012, 452524.
42. Sahu, A., Dube, M.G., Kalra, S.P. & Kalra, P.S. 1988a. Bilateral neural transections at the level of mesencephalon increase food intake and reduce latency to onset of feeding in response to neuropeptide Y. Peptides 9, 1269-1273.
43. Sahu, A., Kalra, S.P., Crowley, W.R. & Kalra, P.S. 1988b. Evidence that NPY-containing neurons in the brainstem project into selected hypothalamic nuclei: implication in feeding behavior. Brain Res 457, 376-378.
44. Sainsbury, A., Rohner-Jeanrenaud, F., Cusin, I., Zakrzewska, K.E., Halban, P.A., Gaillard, R.C. & Jeanrenaud, B. 1997. Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia. Diabetologia 40, 1269-1277.
45. Sawchenko, P.E., Swanson, L.W., Grzanna, R., Howe, P.R., Bloom, S.R. & Polak, J.M. 1985. Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol 241, 138-153.
46. Sell, H., Deshaies, Y. & Richard, D. 2004. The brown adipocyte: update on its metabolic role. Int J Biochem Cell Biol 36, 2098-2104.
47. Shi, Y.C., Lin, S., Castillo, L., Aljanova, A., Enriquez, R.F., Nguyen, A.D., Baldock, P.A., Zhang, L., Bijker, M.S., Macia, L., Yulyaningsih, E., Zhang, H., Lau, J., Sainsbury, A. & Herzog, H. 2011. Peripheral-specific y2 receptor knockdown protects mice from high-fat diet-induced obesity. Obesity (Silver Spring) 19, 2137-2148.
48. Shi, Y.C., Lau, J., Lin, Z., Zhang, H., Zhai, L., Sperk, G., Heilbronn, R., Mietzsch, M., Weger, S., Huang, X.F. et al. 2013. Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN. Cell Metab 17, 236-248.
49. Skurk, T., Alberti-Huber, C., Herder, C. & Hauner, H. 2007. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 92, 1023-1033.
50. Sousa-Ferreira, L., Garrido, M., Nascimento-Ferreira, I., Nobrega, C., Santos-Carvalho, A., Alvaro, A.R., Rosmaninho-Salgado, J., Kaster, M., Kugler, S., de Almeida, L.P. & Cavadas, C. 2011. Moderate long-term modulation of neuropeptide Y in hypothalamic arcuate nucleus induces energy balance alterations in adult rats. PLoS ONE 6, e22333.
51. Stanley, B.G., Kyrkouli, S.E., Lampert, S. & Leibowitz, S.F. 1986. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 7, 1189-1192.
52. Takeda, S., Elefteriou, F. & Karsenty, G. 2003. Common endocrine control of body weight, reproduction, and bone mass. Annu Rev Nutr 23, 403-411.
53. Valet, P., Berlan, M., Beauville, M., Crampes, F., Montastruc, J.L. & Lafontan, M. 1990. Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein. J Clin Invest 85, 291-295.
54. Wang, Q., Wang, M. & Whim, M.D. 2013. Neuropeptide y gates a stress-induced, long-lasting plasticity in the sympathetic nervous system. J Neurosci 33, 12705-12717.
55. Yeung, E.H., Zhang, C., Chen, J., Bowers, K., Hu, F.B., Kang, G. & Qi, L. 2011. Polymorphisms in the neuropeptide Y gene and the risk of obesity: findings from two prospective cohorts. J Clin Endocrinol Metab 96, E2055-E2062.
56. Zarjevski, N., Cusin, I., Vettor, R., Rohner-Jeanrenaud, F. & Jeanrenaud, B. 1993. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 133, 1753-1758.
57. Zhang, L., Macia, L., Turner, N., Enriquez, R.F., Riepler, S.J., Nguyen, A.D., Lin, S., Lee, N.J., Shi, Y.C., Yulyaningsih, E., Slack, K., Baldock, P.A., Herzog, H. & Sainsbury, A. 2010. Peripheral neuropeptide Y Y1 receptors regulate lipid oxidation and fat accretion. Int J Obes (Lond) 34, 357-373.
58. Zhang, L., Lee, I.J., Enriquez, R.F., Lau, J., Vähätalo, L.H., Baldock, P.A., Savontaus, E. & Herzog, H. 2014. Stress- and diet-induced fat gain is controlled by NPY in catecholaminergic neurons. Mol Metab 3, 581-591.
59. Zukowska-Grojec, Z. 1995. Neuropeptide Y. A novel sympathetic stress hormone and more. Ann N Y Acad Sci 771, 219-233.
60. Zukowska-Grojec, Z., Karwatowska-Prokopczuk, E., Rose, W., Rone, J., Movafagh, S., Ji, H., Yeh, Y., Chen, W.T., Kleinman, H.K., Grouzmann, E. & Grant, D.S. 1998. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 83, 187-195.